Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in an article titled "FDA Proposal Aims to Streamline Device Classification According to Risk Medical Symbol."

Following is an excerpt:

According to the FDA, class III devices are the highest risk because they are intended for use in supporting or sustaining human life, are of "substantial importance in preventing impairment of health" or present a "potential unreasonable risk" of illness or injury.

The current regulatory definition doesn't explain the concept of when insufficient information exists to determine that general and special controls would provide a reasonable assurance of safety and effectiveness, the agency said. ...

Bradley Merrill Thompson, an attorney at Epstein Becker & Green PC in Washington and general counsel to the Combination Products Coalition, told Bloomberg BNA the proposed regulation makes sense for combination products "because it merely codifies the existing practice of placing a drug/device combination product in class III where the device is the primary mode of action, but the drug is unproven."

According to Thompson, it makes sense that a drug that hasn't yet been proven safe and effective, when bundled with a device, would lead the device to be placed in class III.

However, Thompson said he was concerned that the proposal states that combination products retain the regulatory identities of their constituent parts but at the same time still recognizes combination products as distinct from products that are sold solely as drugs, devices or biologicals and that might be subject to specialized regulatory controls.

"There is a long-standing debate regarding whether combination products are merely regulated as their underlying constituent parts, or as something of a new category," Thompson said. "We have always resisted the notion that somehow combination products rise to the level of the new category, and it is unsettling for FDA to suggest that there might be specialized controls heaped on these products beyond the existing drug and device requirements. It's a vague statement, so I don't know exactly what they have in mind, but I consider it quite ominous."

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.